about
Five-year disease-free survival among stage II-IV breast cancer patients receiving FAC and AC chemotherapy in phase II clinical trials of Panagen.Properties of internalization factors contributing to the uptake of extracellular DNA into tumor-initiating stem cells of mouse Krebs-2 cell line.A strategy to eradicate well-developed Krebs-2 ascites in miceGene expression profiling of tumor-initiating stem cells from mouse Krebs-2 carcinoma using a novel marker of poorly differentiated cellsComparative analysis of pathologic processes developing in mice housed in SPF vs non-SPF conditions and treated with cyclophosphamide and dsDNA preparation.Nonadherent Spheres With Multiple Myeloma Surface Markers Contain Cells that Contribute to Sphere Formation and Are Capable of Internalizing Extracellular Double-Stranded DNA.Efficacy of a new cancer treatment strategy based on eradication of tumor-initiating stem cells in a mouse model of Krebs-2 solid adenocarcinoma.
P50
Q36107301-9CCBF025-E3C8-4227-9978-AA2577813513Q36938161-06695F6C-6C6D-4E04-A3CB-86B88FC1DB6DQ36998311-A30ED04D-CC2C-4BE2-98A1-E28027B33F61Q39056377-9257A9D8-E712-4FB7-8A1A-5A969FC7BEF7Q41040823-207D29CE-3432-4DAC-ACCB-7EF18089DD3AQ51632567-C1F2D9DB-7A2A-47A4-8DA5-DA0E03F3D7EEQ55452001-C69BABE7-BA5A-433D-AFC0-C9382135DDCA
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Ekaterina A Potter
@en
Ekaterina A Potter
@nl
type
label
Ekaterina A Potter
@en
Ekaterina A Potter
@nl
prefLabel
Ekaterina A Potter
@en
Ekaterina A Potter
@nl
P31
P496
0000-0003-1558-8655